查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143348

醫療設備病毒去活化檢測市場：依病毒類型、檢測方法、應用、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Medical Device Viral Inactivation Testing Market, By Virus Type, By Testing Method, By Application, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，醫療設備病毒去活化測試市場規模將達到 2.107 億美元，並且從 2026 年到 2033 年將以 18.1% 的複合年成長率成長。

醫療設備病毒去活化測試是一項關鍵的檢驗程序，針對與體液和組織接觸的醫療設備進行，旨在評估是否能夠去活化病毒。如果醫療設備醫療設備能夠有效去活化病毒，則可增強人們對病患使用該器械後不會感染的信心。這對於監管機構和製造商至關重要，他們需要確保其產品具備有效的感染控制措施。此測試可確保患者環境中的病毒數量降低至安全水平。這項測試有助於加強感染控制、確保符合監管要求，並提高人們對醫療設備安全性的信心。

醫療設備病毒去活化檢測市場－市場動態

複雜、微創醫療設備的普及推動了市場需求。

複雜、微創醫療設備的普及預計將推動醫療設備病毒去活化檢測市場的成長。這將有助於預防這些器械中各種類型的感染和污染，特別是由危險病毒引起的感染和污染。例如，根據美國國際貿易部（Trade Gov）的數據，截至2026年1月，英國醫療技術行業的銷售額將達到約358億美元，擁有超過13.8萬名員工，4000多家醫療技術公司在英國運營，其中絕大多數（超過85%）為中小企業（SME）。此外，在過去十年中，醫療技術公司的數量增加了200%以上。

英國國家醫療服務體系 (NHS) 承擔了英國85% 的醫療保健支出，每年在醫療技術等臨床產品上的支出平均達 66 億美元。 NHS 在醫療技術方面的支出主要涉及植入和義肢、外科手術設備、診斷設備、靜脈輸液設備、心血管設備和麻醉設備、放射診斷設備以及病患監測技術。預計這一趨勢將進一步增加整體先進醫療設備病毒去活化檢測的需求。

醫療設備病毒去活化檢測市場－市場區隔分析：

全球醫療設備病毒去活化檢測市場按病毒種類、檢測方法、應用和地區進行細分。

在所列病毒種類中，套膜病毒在病毒去活化驗證研究中使用的模型病毒中佔很大比例，並且對常用抗病毒藥物敏感。這有助於確保醫療設備生產和滅菌過程的安全性。 2025年7月，Eurofins BioPharma Product Testing Italy擴大了其位於米蘭的病毒去除服務，以滿足醫療設備業對生物生技藥品和醫療設備病毒去活化和病毒去除測試的需求。預計這一趨勢將進一步增加病毒安全性檢驗中對套膜病毒測試的需求。

在醫療設備病毒去活化檢測市場中，生物相容性檢測是重要的檢測方法區隔領域。這是因為生物相容性檢測能夠在醫療設備上市前或臨床試驗前提供其安全性和生物學特性方面的信息，並且有助於製造商滿足監管要求。 2025年7月，北美醫療器材安全協會（NAMSA）發布了一份關於醫療醫療設備生物學檢測方法的新報告，強調了根據ISO 10993標準進行生物相容性檢測的重要性。該報告強調了基於風險的生物學評估的重要性，包括化學表徵和生物學檢測，取決於醫療設備的應用和接觸。這些活動有助於製造商識別生物風險，並制定相應的檢測策略以用於監管申報。

醫療設備病毒去活化檢測市場—區域分析

由於北美地區擁有高品質的指導方針和監管標準，因此在全球醫療設備病毒去活化檢測市場中佔有重要地位。例如，根據美國食品藥物管理局(FDA) 的數據，截至 2026 年 2 月，該市場主要由三類醫療器材組成：I 類、II 類和 III 類。醫療設備的監管力道從 I 類到 III 類逐漸加強。許多 I 類醫療設備無需進行 510(k) 上市前通知。許多 II 類醫療設備需要獲得 510(k) 批准，而許多 III 類醫療設備需要 PMA（新醫療設備認證）。此外，FDA 也為在美國銷售的醫療設備製定了七項關鍵要求。

這包括企業註冊、醫療設備清單註冊、510(k)或PMA申請、臨床實驗醫療設備豁免(IDE)、品管系統法規(QMSR)、標籤和醫療設備報告(MDR)。目前有12家獲得FDA認可的第三方審查機構，涵蓋總合670種醫療設備。 FDA必須在收到認可機構的建議後30天內做出決定。如此嚴格的法規鞏固了北美作為病毒去活化檢測主要市場的地位。

目錄

第1章：醫療設備病毒去活化檢測市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：醫療設備病毒去活化檢測的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：醫療設備病毒去活化檢測的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：醫療設備病毒去活化檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：醫療設備病毒去活化檢測市場趨勢

  • 2025年醫療設備病毒去活化檢測市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：醫療設備病毒去活化檢測市場：依病毒類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按病毒類型
    • 無套膜病毒
    • 包膜病毒

第8章：醫療設備病毒去活化檢測市場：依檢測方法分類

  • 概述
    • 基於細分市場的市場佔有率分析：按測試方法
    • 化學成分分析
    • 微生物檢驗和可重複使用性檢驗
    • 生物相容性測試

第9章：醫療設備病毒去活化檢測市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 血管醫療設備
    • 體外診斷設備
    • 主動式醫療設備
    • 眼科醫療設備
    • 主動植入醫療設備
    • 其他

第10章：醫療設備病毒去活化檢測市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：醫療設備病毒去活化檢測產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Charles River Laboratories International, Inc.
    • Perfectus Biomed Group
    • Eurofins Scientific
    • Nelson Laboratories
    • Texcell
    • Intertek Group plc
    • LabCorp
    • Syensqo
    • SGS SA
    • Pacific BioLabs
    • Creative Biogene
    • ProPharma Group
    • Cormica Ltd.（Wickham Laboratories Ltd.）
    • CTI
    • WuXi AppTec
    • Q Laboratories
    • BioReliance（MilliporeSigma）
    • ViruSure GmbH
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7589

Medical Device Viral Inactivation Testing market size was valued at US$ 210.7 Million in 2025, expanding at a CAGR of 18.1% from 2026 to 2033.

Medical device viral inactivation testing is an important validation step that is performed on medical devices that come into contact with bodily fluids and tissue in order to assess whether the medical device is able to inactivate any viruses. If the medical device can effectively prove viral inactivation, there is increased assurance that patient infections will not occur due to the use of the device. It is an important factor to regulatory and manufacturing bodies that need to ensure that their products have effective infection control measures. The process ensures that viral load within the patient environment is lowered to a safe level. This testing strengthens infection control, regulatory compliance, and confidence in medical device safety.

Medical Device Viral Inactivation Testing Market- Market Dynamics

Expansion Of Complex And Minimally Invasive Medical Devices To Drive Market Demand

The expansion of complex and minimally invasive medical devices is expected to drive the Medical Device Viral Inactivation Testing market forward. This helps in the prevention of any kind of infections or contamination in such devices, especially by dangerous viruses. For example, in January 2026, according to the U.S. International Trade Administration (Trade Gov), the revenue of the medical technology industry in the UK stands at around $35,800 million (USD), employing more than 138,000 employees, and there are more than 4,000 medical technology firms working in the UK, most of which are SMEs (over 85%). Moreover, the number of medical technology companies has grown by more than 200% in the past ten years.

The National Health Service (NHS) contributes to 85% of the health care in the UK and spends an average of $6,600 million (USD) annually on clinical products that comprise medical technology. The spending of the NHS on medical technology is mostly related to implants and prosthetics; surgical, laboratory, IV, cardiovascular, and anesthesia equipment; radiology; and patient monitoring technologies. This trend is expected to strengthen demand for viral inactivation testing across advanced medical devices.

Medical Device Viral Inactivation Testing Market- Segmentation Analysis:

The Global Medical Device Viral Inactivation Testing market is segmented on the basis of Virus Type, Testing Method, Application, and Region.

Among the given virus types, enveloped viruses account for a prominent share of these viruses as model viruses used in viral inactivation validation studies and are susceptible to common antiviral drugs. It becomes easier to establish the safety of viruses in medical device manufacturing and sterilization processes. In July 2025, Eurofins BioPharma Product Testing Italy offered more viral clearance services in their Milan facility because of viral inactivation tests and viral removal tests on the biologics and medical devices in the medical device industry. This trend is expected to strengthen demand for enveloped virus testing in viral safety validation.

In the Medical Device Viral Inactivation Testing market, the biocompatibility testing segment represents a key testing method segment, as it provides for the safety and biological safety characteristics of a medical device prior to its launch into the market or any clinical trials and is also useful for manufacturing companies in meeting the requirements of regulatory authorities. In July 2025, NAMSA published a new report on biological testing methods for medical devices, emphasizing the biocompatibility testing in accordance with ISO 10993. The report stresses the importance of the risk-based biological evaluation of medical devices that includes chemical characterization and biological testing of the medical device depending on its application and contact. These activities support manufacturers in identifying biological risks and establishing appropriate testing strategies for regulatory submissions.

Medical Device Viral Inactivation Testing Market- Geographical Insights

North America maintains a key position in the global Medical Device Viral Inactivation Testing market, which is explained by the presence of high-quality guidelines and regulatory standards in the region. For instance, in February 2026, according to the U.S. Food and Drug Administration (Gov), the market is made up of 3 major types of devices. These include class I, class II, and class III. Class I to class III show a gradual increase in the regulatory control of devices. Most Class I devices are placed under the exempt category in regard to the need for 510 (k) premarket notification. Most class II devices need 510(k) clearance, while most class III devices require PMA. In addition, the FDA has 7 major requirements for the medical devices available in the United States.

These include establishment registration, device listing, 510(k) or PMA, Investigational Device Exemption (IDE), Quality Management System Regulation (QMSR), labeling, and Medical Device Reporting (MDR). There are 12 FDA-accredited third-party reviewers that cover 670 devices altogether. The FDA has an obligation to give its determination in 30 days after a recommendation by the accredited persons. This regulatory rigor strengthens North America's position as a key market for viral inactivation testing.

Medical Device Viral Inactivation Testing Market- Competitive Landscape:

The global Medical Device Viral Inactivation Testing market, which is globally present, has a competitive landscape that is quite diversified and includes both testing service providers and contract laboratories. Some of the major players that are part of the market and provide not just solutions but also testing facilities and also cater to the safety aspects of the medical device sector include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, and Texcell. The market has the potential to innovate further, considering the increasing biosafety standards and advanced testing capability, among other factors. In January 2026, Charles River Laboratories announced that it intends to purchase the balance approximate 79% equity interest in PathoQuest SAS for approximately USD 60 million, enhancing its advanced next-generation sequencing technology for biopharmaceutical quality control and biosafety testing. The market is poised for continued innovation, driven by expanding biosafety requirements and advanced testing capabilities.

Recent Developments:

In March 2025, Nelson Labs introduced the Rapid Sterility Testing process, applying rapid microbiological techniques to shorten the time required to conduct product sterility tests to just 6 days, from the usual 14-day incubation period, in the medical device and pharmaceutical industries.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Charles River Laboratories International, Inc.
  • Perfectus Biomed Group
  • Eurofins Scientific
  • Nelson Laboratories
  • Texcell
  • Intertek Group plc
  • LabCorp
  • Syensqo
  • SGS SA
  • Pacific BioLabs
  • Creative Biogene
  • ProPharma Group
  • Cormica Ltd. (Wickham Laboratories Ltd.)
  • CTI
  • WuXi AppTec
  • Q Laboratories
  • BioReliance (MilliporeSigma)
  • ViruSure GmbH
  • Others

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY VIRUS TYPE- MARKET ANALYSIS, 2020 - 2033

  • Non-enveloped Viruses
  • Enveloped Viruses

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY TESTING METHOD- MARKET ANALYSIS, 2020 - 2033

  • Chemical Composition Analysis
  • Microbiological & Reusability Validation
  • Biocompatibility Testing

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Vascular Medical Equipment
  • In Vitro Diagnostic Equipment
  • Active Medical Equipment
  • Ophthalmic Medical Equipment
  • Active Implant Medical Devices
  • Others

GLOBAL MEDICAL DEVICE VIRAL INACTIVATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Medical Device Viral Inactivation Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Medical Device Viral Inactivation Testing Key Market Trends

  • 3.1. Medical Device Viral Inactivation Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Medical Device Viral Inactivation Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Medical Device Viral Inactivation Testing Market Opportunities
  • 3.4. Medical Device Viral Inactivation Testing Market Future Trends

4. Medical Device Viral Inactivation Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Medical Device Viral Inactivation Testing Market : Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Medical Device Viral Inactivation Testing Market Landscape

  • 6.1. Medical Device Viral Inactivation Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Medical Device Viral Inactivation Testing Market - By Virus Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Virus Type, 2025 & 2033 (%)
    • 7.1.2. Non-enveloped Viruses
    • 7.1.3. Enveloped Viruses

8. Medical Device Viral Inactivation Testing Market - By Testing Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Method, 2025 & 2033 (%)
    • 8.1.2. Chemical Composition Analysis
    • 8.1.3. Microbiological & Reusability Validation
    • 8.1.4. Biocompatibility Testing

9. Medical Device Viral Inactivation Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Vascular Medical Equipment
    • 9.1.3. In Vitro Diagnostic Equipment
    • 9.1.4. Active Medical Equipment
    • 9.1.5. Ophthalmic Medical Equipment
    • 9.1.6. Active Implant Medical Devices
    • 9.1.7. Others

10. Medical Device Viral Inactivation Testing Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Medical Device Viral Inactivation Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Medical Device Viral Inactivation Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Medical Device Viral Inactivation Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Medical Device Viral Inactivation Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Medical Device Viral Inactivation Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Virus Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Testing Method, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Medical Device Viral Inactivation Testing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Charles River Laboratories International, Inc.
    • 11.2.2. Perfectus Biomed Group
    • 11.2.3. Eurofins Scientific
    • 11.2.4. Nelson Laboratories
    • 11.2.5. Texcell
    • 11.2.6. Intertek Group plc
    • 11.2.7. LabCorp
    • 11.2.8. Syensqo
    • 11.2.9. SGS SA
    • 11.2.10. Pacific BioLabs
    • 11.2.11. Creative Biogene
    • 11.2.12. ProPharma Group
    • 11.2.13. Cormica Ltd. (Wickham Laboratories Ltd.)
    • 11.2.14. CTI
    • 11.2.15. WuXi AppTec
    • 11.2.16. Q Laboratories
    • 11.2.17. BioReliance (MilliporeSigma)
    • 11.2.18. ViruSure GmbH
    • 11.2.19. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us